Clinical Trial Update: Osteogenon in Orthopedics and Traumatology [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates Osteogenon is being studied for healing bone fractures with recruitment ongoing at the University of Opole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fractures

Drugs mentioned

• Osteogenon

Snippet

Sponsor: University of Opole | Conditions: Patients With Fractures | Phase 4 | Status: RECRUITING